Harmony Biosciences Holdings Inc
(NAS:HRMY)
$
34.2
-0.52 (-1.5%)
Market Cap: 1.95 Bil
Enterprise Value: 1.75 Bil
PE Ratio: 16.21
PB Ratio: 3.27
GF Score: 65/100 Harmony Biosciences Holdings Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 11, 2022 / 04:45PM GMT
Release Date Price:
$47.15
(-5.30%)
Ami Fadia
Needham & Company, LLC - Analyst
Good afternoon, everyone. Thank you for joining us today, and it's my pleasure to be hosting Harmony Bioscience. I have with me Jeff Jacobs (sic - "John Jacobs"), President and CEO of the company; and Sandip Kapadia, who is the CFO.
Questions & Answers
Ami Fadia
Needham & Company, LLC - Analyst
Let me just start by kicking off with a question for John.
John Jacobs
Harmony Biosciences Holdings, Inc. - President & CEO
Thank you, Ami.
Ami Fadia
Needham & Company, LLC - Analyst
John, thank you for joining us today. Perhaps I could start by asking you a broad question. We are past the 18-month mark and closing into about two years since the company IPOed.
John Jacobs
Harmony Biosciences Holdings, Inc. - President & CEO
It's hard to believe, yeah.
Ami Fadia
Needham & Company, LLC - Analyst
Exactly. What
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot